Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Allergan, Inc.
(NY:
AGN
)
101.41
USD
+0.99 (+0.99%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Allergan, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Allergan, Inc About To Put More Money In Your Pocket (AGN)
May 17, 2013
On 5/21/13, Allergan, Inc (AGN) will trade ex-dividend, for its quarterly dividend of $0.05, payable on 6/13/13. As a percentage of AGN's recent stock price of $100.53, this dividend works out to...
Read More
category
Dividends
from
Dividend Channel
Long-Term Growth from Underlying Strength
May 17, 2013
We calibrate the Growth Portfolio and also reaffirm our commitment to Apple, a company that's taken a few hits but remains in fighting shape.
Read More
from
Update Content Feed for Financial Content
IHE, PFE, AGN, ACT: Large Outflows Detected at ETF
May 10, 2013
Symbols mentioned in this story: IHE, PFE, AGN, ACT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
New Stock Coverage: Frozen Smiles All Around at Allergan
May 10, 2013
Wall Street ratings agencies set the tone for today's stock market.
Read More
category
AGN
from
Minyanville Headlines
Benzinga's Top Initiations
May 10, 2013
Analysts at Wedbush initiated coverage on shares of Interactive Intelligence Group (NASDAQ: ININ ) with a “neutral” rating. The target price range for Interactive Intelligence Group is set to $53....
Read More
category
NUAN
,
Benzinga
,
Initiation
, and 5 more.
from
Latest Articles from Benzinga.com
BMO Capital Starts Allergen (AGN) at Outperform
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8324837 for the full story.
Read More
from
StreetInsider.com News Articles
The Next Billionaire: A Statistician Who Changed Medicine
May 08, 2013
Over the next few days, Dennis Gillings, a statistician who helped create the multibillion-dollar industry of conducting research studies for drug giants, is likely to enter an exclusive club: those...
Read More
category
NYSE:CVD
,
NYSE:AGN
,
NYSE:Q
, and 1 more.
from
Forbes Real Time
UPDATE 1-Insurer Aegon's net profit tumbles on equity hedging
May 08, 2013
AMSTERDAM, May 8 (Reuters) - Dutch insurer Aegon said first-quarter net profit fell nearly two thirds because of hedging losses resulting from an unexpectedly strong rise in U.S. stocks, particularly...
Read More
category
companyNews
from
Reuters: Company News
BRIEF-Aegon shares fall after Q1 results
May 08, 2013
AMSTERDAM, May 8 (Reuters) - Aegon NV : * Shares open down 0.8 percent after Q1 results
Read More
category
companyNews
from
Reuters: Company News
Gastric banding: Pros and cons of Christie's surprising choice
May 07, 2013
May 7 (Reuters) - New Jersey Governor Chris Christie's choice of gastric banding has prompted questions about why he opted for a weight-loss procedure less favored by bariatric surgeons and patients.
Read More
category
companyNews
from
Reuters: Company News
Starbucks, Huntington Bancshares and Other Stocks Insiders Are Buying
May 04, 2013
Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they...
Read More
category
OPK
,
Benzinga
,
FITB
, and 34 more.
from
Latest Articles from Benzinga.com
Recent Dip May Provide Long-Term Opportunity on Allergan (AGN) - Cramer
May 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8303184 for the full story.
Read More
from
StreetInsider.com News Articles
RPT-Fitch affirms Aegon's ratings; outlook negative
May 03, 2013
May 3 (Reuters) - (The following statement was released by the rating agency)
Read More
category
companyNews
from
Reuters: Company News
Cramer: Did Allergan Deserve 10% Decline?
May 02, 2013
Investors obliterated shares of Allergan earlier in the week, sending the stock down more than 10% in a single session. Was the stock oversold?
Read More
category
Investing
,
tvcodes/tvearn
,
Mad Money for Mobile
, and 11 more.
from
CNBC.com News
FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-Face
May 02, 2013
Allergan (NYSE: AGN ) is pleased that the U.S. Food and Drug Administration (FDA) General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee has voted unanimously that the...
Read More
category
Benzinga
,
News
,
FDA
, and 1 more.
from
Latest Articles from Benzinga.com
Analyst Moves: REGN, AGN, STX
May 02, 2013
This morning, JMP upgraded shares of Regeneron (REGN) from market perform to outperform as the company's newest cholesterol drug will boost future earnings. With the upgrade, JMP set a $290 price...
Read More
category
Stocks
from
Market News Video
Notable Analyst Rating Changes 05/02: (AGN) (IVZ) (ACI) Upgraded; (WPZ) (MU) (RBA) Downgraded
May 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8298868 for the full story.
Read More
from
StreetInsider.com News Articles
Lazard Capital Upgrades Allergen (AGN) to Buy
May 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8297474 for the full story.
Read More
from
StreetInsider.com News Articles
Jim Cramer: Common Drug Stock a Mistake
May 01, 2013
If you're among the skeptics selling drug stocks for this reason, Cramer thinks you don't get the pharma business.
Read More
category
Regeneron Pharmaceuticals Inc
,
Biotechnology
,
Merck & Co Inc
, and 13 more.
from
CNBC.com News
Regeneron Pharma Surges As Rival Allergan Tumbles
May 01, 2013
The market suffered a big setback Wednesday, but a round of top-rated stocks managed to buck the trend and put in new highs. Biotech Regeneron Pharmaceuticals (REGN) shot up to a record high on news...
Read More
category
New Highs
from
Investor's Business Daily - Investing RSS
Dividend Highlights/Lowlights for May 1
May 01, 2013
These were some of the biggest dividend stock performers on the upside and the downside in today’s market action. Highlights NYSE Euronext (NYX) – up 2% Aon Corp (AON) – up 2% Aetna (AET) – up 1%...
Read More
category
aet
,
emn
,
aon
, and 10 more.
from
Dividend Daily
Regeneron Pharmaceuticals: The Stock That Only Goes Up?
May 01, 2013
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN ) were trading at new all-time high levels on Wednesday afternoon on concerns that rival Allergan (NYSE: AGN ) may have problems moving its unnamed...
Read More
category
Benzinga
,
REGN
,
Movers
, and 10 more.
from
Latest Articles from Benzinga.com
Market Wrap-Up for May 1 (MA, MRK, CMI, EMN, VIA, AAPL, more)
May 01, 2013
We definitely had a more cautionary start to the new month for investors. Part of the nervousness could be related to survey results from ADP indicating companies in the private sector added less...
Read More
category
eqr
,
hum
,
emn
, and 7 more.
from
Dividend Daily
Market Wrap for Wednesday, May 1: Stocks Fall as Employment Data Weakens in April
May 01, 2013
The U.S. stock market was hit hard on Wednesday as investors reacted to a report which showed slowing employment conditions for the month of April. The losses were also likely amplified by profit...
Read More
category
Earnings
,
Benzinga
,
REGN
, and 25 more.
from
Latest Articles from Benzinga.com
Allergan, Inc (AGN) Shares Cross Below 200 DMA
May 01, 2013
In trading on Wednesday, shares of Allergan, Inc (AGN) crossed below their 200 day moving average of $97.45, changing hands as low as $96.77 per share. Allergan, Inc shares are currently trading off...
Read More
category
Stocks
from
Market News Video
Mid-Afternoon Market Update: Markets Remain Down as Allergan Continues to Fall
May 01, 2013
Toward the end of trading Wednesday, the Dow traded down 0.87 percent to 14,710.49 while the NASDAQ declined 0.83 percent to 3,301.88. The S&P also fell, dropping 0.87 percent to 1,583.04. Index...
Read More
category
Earnings
,
Benzinga
,
Movers
, and 17 more.
from
Latest Articles from Benzinga.com
Notable 52-Week Highs and Lows of the Day 05/01: (SIRI) (VIAB) (REGN) High; (ANV) (MELA) Low
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8294886 for the full story.
Read More
from
StreetInsider.com News Articles
Morgan Stanley Downgrades Allergen (AGN) to Equalweight
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8294796 for the full story.
Read More
from
StreetInsider.com News Articles
Manufacturing Index Slips, Markets Extend Losses
May 01, 2013
The markets extended its losses during the midday with the Dow dropping 76 points to 14,763 as expansion of manufacturing activity slowed in April. Nasdaq fell 21 points to 3307.
Read More
category
Market News
from
MarketMinute.com Market Updates
Midday Movers: H, AMT, ICE & More
May 01, 2013
Take a look at some of Wednesday's midday movers:
Read More
category
Regeneron Pharmaceuticals Inc
,
Realogy Corp
,
Estee Lauder Companies Inc
, and 7 more.
from
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.